A
Apogee Therapeutics, Inc. (APGE)
NGM – Цена в реальном времени. Валюта: USD
134.84
+0.35 (0.26%)
При закрытии: Aug 07, 2026, 3:59 PM EDT
Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций
Find any stock by ticker or company name
NGM – Цена в реальном времени. Валюта: USD
134.84
+0.35 (0.26%)
При закрытии: Aug 07, 2026, 3:59 PM EDT
| Состав | |
|---|---|
| 2.33% | % акций у инсайдеров |
| 110.65% | % акций у институциональных инвесторов |
| 113.29% | % свободных акций у институциональных инвесторов |
| 352 | Количество институциональных инвесторов |
| Держатель | Акции | Дата отчёта | % от объёма | Стоимость |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.30M | 2026-03-31 | 16.65% | $1.39B |
| FMR, LLC | 9.26M | 2026-03-31 | 14.97% | $1.25B |
| Venrock Adviser, LLC | 8.49M | 2026-03-31 | 13.73% | $1.15B |
| Wellington Management Group, LLP | 4.38M | 2026-03-31 | 7.07% | $590.02M |
| Blackrock Inc. | 4.09M | 2026-03-31 | 6.60% | $550.91M |
| RTW Investments LP | 2.78M | 2026-03-31 | 4.50% | $375.14M |
| Vanguard Capital Management LLC | 2.50M | 2026-03-31 | 4.04% | $337.38M |
| Janus Henderson Group PLC | 2.36M | 2026-03-31 | 3.81% | $318.30M |
| State Street Corporation | 2.16M | 2026-03-31 | 3.50% | $291.65M |
| Driehaus Capital Management, LLC | 1.92M | 2026-03-31 | 3.10% | $259.00M |
| Держатель | Акции | Дата отчёта | % от объёма | Стоимость |
|---|---|---|---|---|
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 5.30M | 2026-03-31 | 8.56% | $714.10M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.84M | 2026-03-31 | 2.97% | $248.15M |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.84M | 2026-05-31 | 2.97% | $246.92M |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.49M | 2026-04-30 | 2.41% | $201.01M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.20M | 2026-06-30 | 1.94% | $161.70M |
| iShares Trust-iShares Russell 2000 ETF | 1.16M | 2026-06-30 | 1.88% | $157.02M |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 1.13M | 2026-03-31 | 1.82% | $151.79M |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 802,067 | 2026-03-31 | 1.30% | $108.15M |
| T. Rowe Price Health Sciences Fund, Inc. | 637,936 | 2025-12-31 | 1.03% | $52.96M |
| T. Rowe Price Exch-Trd Fd.s, Inc.-T Rowe Price Capital Appreciation Eq | 634,849 | 2026-03-31 | 1.03% | $85.60M |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 624,163 | 2026-05-31 | 1.01% | $83.83M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 598,603 | 2026-03-31 | 0.97% | $80.72M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 557,423 | 2026-03-31 | 0.90% | $75.16M |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 543,388 | 2026-03-31 | 0.88% | $44.63M |
| Vanguard Explorer Fund | 530,576 | 2026-01-31 | 0.86% | $41.29M |
| Voya Investors TRT-VY(R) T. Rowe Price Capital Appreciation PORT. | 523,799 | 2026-03-31 | 0.85% | $43.63M |